Navigation Links
Nektar Therapeutics Reports Third Quarter 2011 Financial Results
Date:11/2/2011

ResultsNektar management will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT) today, Wednesday, November 2, 2011.

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through December 1, 2011.

To access the conference call, follow these instructions:

Dial: (866) 203-3436 (U.S.); (617) 213-8849 (international)
Passcode: 16610535 (Nektar Therapeutics is the host)

An audio replay will also be available shortly following the call through Thursday, December 1, 2011 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 41636531.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for NKTR-118, an investigational drug candidate, being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation.  The agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of NKTR-118 and an opioid.  NKTR-
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... CVS Health Corporation (NYSE: CVS ) ... 1, 2015, at 8:30 a.m. (EDT) with analysts and ... An audio webcast of the conference call will ... the CVS Health website for all interested parties. To ... will be archived and available on the web site ...
(Date:4/17/2015)... ASSESS shows   plasma circulating tumour DNA ... to tumour biopsy   IGNITE supports value ...   AstraZeneca today presented results from two key ... testing for epidermal growth factor receptor (EGFR) mutation status in ... in clinical practice. [ 1 ] , ...
(Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... of the "Mammography Equipment - Global Strategic Business ... report analyzes the worldwide markets for Mammography Equipment in ... Equipment, and Digital Mammography Equipment. The report provides separate ... , Japan , Europe ...
Breaking Medicine Technology:"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2
... , ... 1 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc., (NYSE Amex: ... medicine ("TCM") based in Chengdu, China, today,announced that it ... Drug,Administration (SFDA) to produce Pediatric Fever and Cough Oral ...
... 1 Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical ... injection, USP and ceftriaxone for injection, USP. Both are antibiotics ... gram-negative bacteria. Sagent will launch ceftriaxone in a 10 g ... by Sagent in July 2008. Cefoxitin 1 g and ...
Cached Medicine Technology:Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2
(Date:4/18/2015)... 2015 Aureus Medical Group (web: ... physical therapy jobs, has announced that it will ... Physical Therapy Association Annual Conference to be held ... Greenville, SC. , The SCAPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant affordable ... Celebration on April 20 with a day full of ... and soul. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... Week is observed every April and highlights the communities ...
(Date:4/17/2015)... York, NY (PRWEB) April 18, 2015 ... at their facility, rounding out their list of diagnostic ... care center for patients on the Upper East Side ... and running at full capacity. The addition of PET-CT, ... gives their physicians the ability to work with patients ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 ... Dr. Kevin Sadati of the Gallery of ... Orange County’s top beauty experts. The publication focused ... lift, facial stem cell fat grafting, eyelid surgery, laser ... facial plastic surgery has resulted in thousands ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3
... transient ischaemic attack (TIA), sometimes referred to as a "mini ... in the first year if their care was co-ordinated by ... a study published in the November issue of the ... Department of Neurology at Aarhus University Hospital in Denmark studied ...
... THURSDAY, Oct. 27 (HealthDay News) -- Older people who ... greater risk for complications and disability following surgery, according ... of Colorado said surgeons should assess the elderly differently ... when determining surgical risks. "This approach may lead ...
... found that a childhood behavioral intervention to lower dietary ... consumption of foods that are good sources of dietary ... and lower systolic blood pressure when study participants were ... publication in The Endocrine Society,s Journal of Clinical ...
... therapy was found to be ineffective in reducing ... lupus erythematosus (SLE). Results of the Atherosclerosis Prevention ... in Arthritis & Rheumatism , a journal ... College of Rheumatology (ACR), report that the statin ...
... doctors at the University of California, San Francisco indicates that a ... a study reported in the Oct. 27, 2011 issue of ... less common than other forms of the disease in the United ... is particularly common among men who have sex with men and ...
... By Alan Mozes HealthDay Reporter , WEDNESDAY, ... promises of popular probiotic yogurts to the test and found ... metabolized. But whether that means probiotic foods and supplements ... "Federal regulatory agencies are increasingly interested in evaluating all ...
Cached Medicine News:Health News:Hospital team significantly reduced risk of further vascular events after 'mini strokes' 2Health News:Hospital team significantly reduced risk of further vascular events after 'mini strokes' 3Health News: Slower Walking Speed Linked to Surgical Risk in Elderly 2Health News: Slower Walking Speed Linked to Surgical Risk in Elderly 3Health News:Childhood diet lower in fat and higher in fiber may lower risk for chronic disease in adulthood 2Health News:Statin therapy fails to slow progression of atherosclerosis in pediatric lupus patients 2Health News:Clinical trial shows first evidence that anal cancer is preventable 2Health News:Clinical trial shows first evidence that anal cancer is preventable 3Health News:Science Probes How Probiotic Yogurts Affect Your Gut 2Health News:Science Probes How Probiotic Yogurts Affect Your Gut 3
The Guidant INSIGNIA Ultra pacing system offers sophisticated patient-specific, easy-to-use features for simplified patient management and enhanced patient safety....
... A small portable unit weighing less ... offers extreme dependability and uncompromising image quality. ... this system is a cost effective solution ... EUB-405s sealed keyboard is durable and easy ...
The EUB-525 is a mid-size system with a full feature set. Capable of B-mode, M-mode, Doppler, Color Flow and Color Angiography it performs a variety of tasks in a simple and straightforward fashion....
... 6500 high resolution digital ultrasound ... enhanced operating efficiency, and remarkable ... and versatile configuration that simply ... in a variety of real-world, ...
Medicine Products: